Major Adverse Cardiovascular Events Associated with Post-Operative Atrial Fibrillation after Non-Cardiac Surgery: A Systematic Review and Meta-analysis

Cardiovascular Risk and Diseases

Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies

J Am Heart Assoc.

Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L

doi: 10.1161/JAHA.116.004947.

Heart, Artery and Coronary Diseases

Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis

Heart.

Koshy AN, Ha FJ, Gow PJ, Han HC, Amirul-Islam FM, Lim HS, Teh AW, Farouque O

doi: 10.1136/heartjnl-2018-314649.

Atrial Fibrillation

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

Eur Heart J.

Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T, Vranckx P, Valgimigli M

doi: 10.1093/eurheartj/ehz732.

Cardiac Arrest or DeathCardiovascular Risk and DiseasesAtrial FibrillationHeart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention

Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation

Eur Heart J.

Polovina M, Hindricks G, Maggioni A, Piepoli M, Vardas P, Ašanin M, Ðikic D, Ðuricic N, Milinkovic I, Seferovic PM

doi: 10.1093/eurheartj/ehy446.

Cardiovascular Risk and Diseases

Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial

JAMA Cardiol.

Verma S, Bain SC, Buse JB, Idorn T, Rasmussen S, Ørsted DD, Nauck MA

doi: 10.1001/jamacardio.2019.3080.

Cardiac Arrest or DeathMyocardial InfarctionThrombosis and Stroke

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis

BMJ

Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, Smith M, Archer L, Levis B, Payne RA, Riley RD, Roberts N, Snell KIE, Lay-Flurrie S, Usher-Smith J, Stevens R, Hobbs FDR, McManus RJ, Sheppard JP, STRATIFY investigators.

doi: 10.1136/bmj.n189

Heart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention

Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery

JACC Cardiovasc Interv.

Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT Author information

doi: 10.1016/j.jcin.2016.11.001.

Cardiovascular Risk and DiseasesAtrial FibrillationHeart, Artery and Coronary DiseasesHeart FailureHypertensionThrombosis and Stroke

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

Lancet Diabetes Endocrinol.

Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P

Atrial FibrillationHeart, Artery and Coronary Diseases

The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials

Circulation.

Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM

doi: 10.1161/CIRCULATIONAHA.

Related content